Filter
Reset all

Subjects

Content Types

Countries

API

Certificates

Data access

Data access restrictions

Database access

Data licenses

Data upload

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 6 result(s)
Country
<<<!!!<<< The website www.geobase.ca/ closed in January 2015. >>>!!!>>> All GeoBase products are available on the Open Government of Canada portal: https://open.canada.ca/data/en/dataset?q=geobase&organization=nrcan-rncan GeoBase initiative provides geospatial data of the entire Canadian landmass for government, business, and/or personal assessments of sustainable resource development, public safety, sanitation, and environmental protection. Data is available for download as ESRI Shapefile, FGDB, KML, and GML.
Country
The Organelle Genome Megasequencing Program (OGMP) provides mitochondrial, chloroplast, and mitochondrial plasmid genome data. OGMP tools allow direct comparison of OGMP and NCBI validated records. Includes GOBASE, a taxonomically broad organelle genome database that organizes and integrates diverse data related to mitochondria and chloroplasts.
Country
The data page makes the data that PCIC collects and produces publicly available with an open license. The page presently provides access to BC Station Data, High-Resolution Climatology, Downscaled Climate Scenarios and VIC Hydrologic Model Output and Extreme Indices calculated from CMIP5.
Country
An Open Science resource that promotes scientific research and discovery in neurological diseases and accelerates the development of new treatments. It includes a growing collection of biospecimens, longitudinal clinical and neuropsychiatric information, imaging and genetic data from patients with neurological disease as well as healthy controls.